Fellows of the British Pharmacological Society are members who have demonstrated distinction and peer recognition in pharmacology.
Fellows have made, and may continue to make, substantial contributions to the disciplines of pharmacology, clinical pharmacology and therapeutics, through their work, publication and presentation of research, leadership, and contribution to Society life.
Find out more and apply for Fellowship.
This directory has been created to increase the visibility of our Fellows and their contributions, and to support networking by providing a useful resource for members to connect with Fellows with similar areas of interest.
Here you can find profiles of each Fellow, including information on their institutional affiliation, year elected, primary professional setting, affinity group membership, and a short biography.
Select the magnifying glass icon to begin any searches.
Dr Bell received his PhD in Cardiovascular Pharmacology from QUB, investigating regulation of myocardial contractility by cardioendocrine peptides.
Lynne Bollington is the lead consultant for the Prescribing Safety Assessment (PSA) and the Editor-in-Chief of BPS Assessment Ltd.
Alan Boobis is Professor of Biochemical Pharmacology at Imperial College London.
Sophie completed her CASE PhD in molecular pharmacology at the University of Leicester (supported by GlaxoSmithKline), under the supervision of Prof John Challiss.
Dr Brain graduated with a PhD in Physiology in 1998 and in Medicine in 1999 from the University of Sydney, Australia.
Lecturer in Pharmacology at School of Pharmacy, Brighton University and then the Welsh School of Pharmacy, Cardiff University, rising to Professor of Pharmacology.
James was born and raised in Cardiff and graduated with a BSc (Hons) Pharmacology from Portsmouth Polytechnic in 1990, He completed his PhD at the University of Aston and Wellcome Research Laboratories (Beckenham, Kent), before joining Sandoz Pharmaceuticals as a Clinical Research Associate.
Morris Brown, FMedSci, was the Foundation Professor of Clinical Pharmacology in the University of Cambridge and established the Wellcome Trust/GSK interdisciplinary programme in Translational Medicine and Therapeutics.